Trilobio, developer of complete lab automation options for advancing biology analysis, at present launched the primary model of its complete robotics, lab tools and software program platform on the Society for Laboratory Automation and Screening convention, SLAS2025, alongside pilot buyer knowledge, demonstrating the platform’s skills in advancing analysis workflows.
Trilobio was based to enhance genetic engineering, artificial biology and life science analysis processes by constructing robotic lab automation modules coupled with an software retailer to package deal and distribute lab protocols as code. The Firm is deploying absolutely automated labs that deal with knowledge high quality and reproducibility challenges to enhance analysis inefficiencies, whereby it’s estimated that 77% of biologists can not reproduce their very own or different’s analysis, regardless of newest advances in laboratory automation instruments.
Our platform is constructed by biologists for biologists. We’re happy to be showcasing our platform for the primary time at SLAS2025. We have constructed Trilobio from the angle of the biologist, with the understanding that full-integration and automation can unlock the total potential of analysis. This has led us to develop a platform that lets biologists use our robots half-hour after unboxing, design analysis protocols in minutes (not days), and get entry to those capabilities at an reasonably priced worth.”
Roya Amini-Naieni, CEO and Co-founder, Trilobio
The Trilobio platform contains the Trilobot lab robotic, analysis gadgets (gripper, pipettes, and tube handlers), and the Trilobio OS analysis protocol software program. It’s purpose-built to make sure all analysis protocols designed and executed on the platform are reproducible in every other Trilobio-enabled lab. By facilitating complete lab operations to be automated, the Firm’s mission is to assist biologists to maximise the potential of their analysis simply, precisely, and reliably. A key focus is overcoming the fee, complexity, configuration and coaching hurdles that stop scientists from adopting automation extra broadly.
Trilobio was co-founded by Roya Amini-Naieni and Maximilian Schommer in 2021, who had been named on Forbes’ 30 Beneath 30 checklist for his or her contributions to advances in Manufacturing & Trade. To-date, the Firm has raised $3 million USD in a pre-seed spherical led by Argon Ventures and Lowercarbon Capital. The Trilobio platform is already deployed at main biology labs and has generated validating knowledge from preliminary pilot packages. together with on the Leconte Group, a genetic engineering tutorial lab on the Keck Science Division of the Claremont Faculties, Abalone Bio, an artificial biology firm creating novel antibodies for difficult illness targets, and Triton Bio, a biotechnology firm offering novel bioinstruments.
Aaron Leconte, Affiliate Professor of Chemistry at W.M. Keck Science Division stated: “The Trilobot is the primary low-cost automation system the place I may genuinely see giving over extra of the experimental accountability to the robotic. It’s extra dependable than different programs. With different programs, we frequently have to observe the system for dropped pipette ideas or errors in supply, however we’ve got not had to do this with the Trilobot.”
Lorenzo D’Amico, CEO and Founder, Triton Bio stated: “We’ve got simply saved 80 hours of coaching time for brand new staff. Our technician was freed as much as spend not less than 2 hours per day engaged on different duties. In our operation, we elevated knowledge manufacturing by round 25% – the Trilobot is way extra succesful than the competitors and has the potential to supply true walk-away automation.”
Monica Schwartz, VP of Antibody Discovery at Abalone Bio stated: “With a Trilobot executing our assays, we drastically cut back human error and each guarantee larger consistency and accuracy. Trilobio ensures that our cultures are moved to the right nicely and the right pipette quantity each time. Additionally, the Trilobot can put extra samples on a plate than a human, which has elevated our testing throughput by 33%.”
The muse of the Trilobio platform is the Trilobot, a multifunctional robotic constructed on standardized {hardware} and software program; enabling operation of any Trilobio analysis instrument and intermodular collaboration between Trilobots to scale up analysis operations. Trilobio OS is the software program engine of the platform, combining protocol design, optimization, and execution with an automatic lab pocket book and LIMS. It allows biologists to design superior analysis protocols through a no-code GUI quite than machine code. Trilobio OS determines the optimum execution of the protocol and biologists can mechanically optimize any protocol for velocity, value or accuracy. By combining the standardized {hardware} of the Trilobot and with the revolutionary software program of Trilobio OS, all analysis protocols constructed on the platform are reproducible on every other Trilobio configuration with out the necessity to recalibrate Trilobots or rewrite protocols.